Work

Supplementary Table 1 from Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer

Year: 2024

Type: supplementary-materials

Abstract: Characteristics of trial patients

DOI: 10.1158/2326-6066.25540806

Authors: Hewitt Chang, Jaqueline Marquez, Brandon K. Chen, Daniel M. Kim, Michael L. Cheng, Eric V. Liu, Hai Yang, Li Zhang, Meenal Sinha, Alexander Cheung, Serena S. Kwek, Eric D. Chow, Mark Bridge, Rahul R. Aggarwal, Terence W. Friedlander, Eric J. Small, Mark Anderson, Lawrence Fong

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4393934003

Cites:

Cited by:

Related to: 10